Navigation Links
invivodata and PRO Consulting to Present at International Industry Events
Date:3/2/2009

PITTSBURGH, March 2 /PRNewswire/ -- invivodata, inc., (http://www.invivodata.com) the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced a series of featured presentations at upcoming international events to be delivered by representatives from invivodata and its scientific and regulatory consulting division, PRO Consulting(R) (http://www.patientreported.com).

Scientific, regulatory, and technical experts from invivodata and PRO Consulting will share their knowledge on the collection of Patient Reported Outcomes (PRO) data and e-clinical technologies at the following industry events:

  • Association of Clinical Data Management (ACDM) Annual Meeting (8-9 March 2009 in Northamptonshire, UK). invivodata's Adam Wood will present "ePRO Evolution and its impact on Clinical Data Management".

  • Drug Information Association (DIA) Annual EuroMeeting (23-25 March 2009 in Berlin, Germany). invivodata's Vice President, Europe and Asia Pacific, Dr. Wolfgang Summa will present "Integration of Direct Data Capture, ePRO and EDC Data via CDISC ODM".

  • Annual eClinical Trials Conference (13-14 May, 2009 in London, UK). Dr. Wolfgang Summa will present "The Impact of CDISC on e-Clinical Trials" at Vision in Business' conference.

  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting (16-20 May, 2009 in Orlando, FL). PRO Consulting Scientist, Dr. Chad Gwaltney will lead a workshop presentation on "Establishing the Content Validity of PRO Instruments".

Pharmaceutical research professionals can also learn more at ePROficiency(TM) 2009, invivodata's annual Patient Reported Outcomes Conference (http://www.invivodata.com/ePRO2009). Attendees of this conference, which begins April 21, 2009 in Naples, FL, can participate in general PRO sessions and various peer-led tracks focused on PRO regulatory guidelines and implications, industry and scientific trends, and best practices for designing and executing ePRO systems in clinical research.

Additional information on ePROficiency 2009 and other upcoming presentations by invivodata and PRO Consulting scientists can be found at http://www.invivodata.com/news-events/events or www.patientreported.com.

About invivodata, inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata's solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

About PRO Consulting

PRO Consulting, a division of invivodata, inc., provides consulting services to help clinical research teams effectively develop, execute, and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has more than 140 years of cumulative experience in psychometrics, PRO study design, migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies. For more information please visit http://www.patientreported.com.

    For more information, contact:

    Invivodata, inc.
    Christine Tobin
    Corporate Communications Specialist
    (412) 390-3000, ext. 3502
    ctobin@invivodata.com


'/>"/>
SOURCE invivodata, inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Pharsight Expands Strategic Consulting Services Team
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
4. Tunnell Consulting Expands Biotechnology Expertise
5. Quintiles Consulting Business Expands
6. Cliff Consulting, Inc. Adds Two Influential Former Executives to Its Team - Banker Mary P. Carryer and Healthcare IT Leader Robert Goldstein
7. Symphony Managemnt Consulting Hires New Solutions Director
8. Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services
9. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
10. Balan Biomedical, Inc. Announces the Formation of Battery Consulting Group
11. Fuld & Company Announces Appointment of MIT Fellow to Head Pharmaceutical Teams Strategic Gaming and Consulting Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
Breaking Biology News(10 mins):